Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Dec. 30, 2023
Statement of Cash Flows [Abstract]      
Cash and cash equivalents, beginning of period $ 8,249 $ 7,079 $ 11,144
Cash flows provided by (used for) operating activities:      
Net income (loss) 26 (19,233) 1,675
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 10,757 9,951 7,847
Share-based compensation 2,434 3,410 3,229
Restructuring and other charges 476 3,491 (424)
Amortization of intangibles 949 1,428 1,755
(Gains) losses on equity investments, net (514) (246) (42)
Mark-to-market (gains) losses on Escrowed Shares 1,796 0 0
(Gains) losses on divestitures (5,323) 0 0
Deferred taxes 328 6,132 (2,033)
Impairments and net (gain) loss on retirement of property, plant and equipment 515 2,252 33
Changes in assets and liabilities:      
Accounts receivable (449) (75) 731
Inventories (138) (1,105) 2,097
Accounts payable 297 634 (801)
Accrued compensation and benefits 788 (218) (614)
Income taxes (995) (356) (1,498)
Other assets and liabilities (1,250) 2,223 (484)
Total adjustments 9,671 27,521 9,796
Net cash provided by (used for) operating activities 9,697 8,288 11,471
Cash flows provided by (used for) investing activities:      
Additions to property, plant and equipment (14,646) (23,944) (25,750)
Proceeds from capital-related government incentives 1,577 1,936 1,011
Purchases of short-term investments (24,319) (37,940) (44,414)
Maturities and sales of short-term investments 15,387 41,463 44,077
Sales of equity investments 671 1,047 472
Proceeds from Divestiture of Businesses 6,157 0 0
Other investing 352 (818) 563
Net cash provided by (used for) investing activities (14,821) (18,256) (24,041)
Cash flows provided by (used for) financing activities:      
Issuance of commercial paper, net of issuance costs 3,493 7,349 0
Repayment of commercial paper (3,493) (7,349) (3,944)
Partner contributions 5,108 12,714 1,511
Net proceeds from sales of subsidiary shares 921 0 2,959
Additions to property, plant and equipment (3,026) (1,178) 0
Issuance of long-term debt, net of issuance costs 0 2,975 11,391
Repayment of debt (3,750) (2,288) (423)
Proceeds from sales of common stock through employee equity incentive plans 771 987 1,042
Net proceeds attributed to common stock and warrants issued, and Escrowed Shares 12,706 0 0
Restricted stock unit withholdings (423) (631) (534)
Payment of dividends to stockholders 0 (1,599) (3,088)
Other financing (720) 158 (409)
Net cash provided by (used for) financing activities 11,587 11,138 8,505
Net increase (decrease) in cash and cash equivalents 6,463 1,170 (4,065)
Cash, cash equivalents, and restricted cash, end of period 14,712 8,249 7,079
Non-cash supplemental disclosures:      
Acquisition of property, plant and equipment 4,952 8,125 4,804
Interest, net of capitalized interest $ 1,106 $ 987 $ 613